NCT03539705

Brief Summary

This is a registry of participants who are interested in being screened for clinical trials at a single site.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6,000

participants targeted

Target at P75+ for all trials

Timeline
23mo left

Started Jan 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Jan 2018May 2028

Study Start

First participant enrolled

January 5, 2018

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 16, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 29, 2018

Completed
9.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2028

Last Updated

November 14, 2025

Status Verified

November 1, 2025

Enrollment Period

10.3 years

First QC Date

May 16, 2018

Last Update Submit

November 12, 2025

Conditions

Allergy and Asthma

Outcome Measures

Primary Outcomes (1)

  • Registry to provide a list of interested individuals in clinical trials at a single site

    The clinical trials could be either allergy or asthma studies

    4 years

Interventions

There is no interventionOTHER

There is no intervention

Eligibility Criteria

Age0 Years - 100 Years
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Any interested party from 0-100 yrs of age to enter their information in registry

You may qualify if:

  • Any interested party from 0-100 yrs of age to enter their information in registry

You may not qualify if:

  • Any individual who does not consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University

Palo Alto, California, 94304, United States

RECRUITING

MeSH Terms

Conditions

HypersensitivityAsthma

Condition Hierarchy (Ancestors)

Immune System DiseasesBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, Immediate

Study Officials

  • Sharon Chinthrajah

    Stanford University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

SNP Center Inquiry

CONTACT

650-521-7237snpcenterallergy_inquiry@stanford.edu

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, Associate Professor

Study Record Dates

First Submitted

May 16, 2018

First Posted

May 29, 2018

Study Start

January 5, 2018

Primary Completion (Estimated)

May 1, 2028

Study Completion (Estimated)

May 1, 2028

Last Updated

November 14, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations

US(1)